ATE398623T1 - Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer - Google Patents

Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Info

Publication number
ATE398623T1
ATE398623T1 AT00966144T AT00966144T ATE398623T1 AT E398623 T1 ATE398623 T1 AT E398623T1 AT 00966144 T AT00966144 T AT 00966144T AT 00966144 T AT00966144 T AT 00966144T AT E398623 T1 ATE398623 T1 AT E398623T1
Authority
AT
Austria
Prior art keywords
carbamat
hexahydrofuro
ylsulfonyl
benzodioxol
furan
Prior art date
Application number
AT00966144T
Other languages
English (en)
Inventor
Piet Wigerinck
Guangyang Wang
Michael Eissenstat
John Erickson
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE398623T1 publication Critical patent/ATE398623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00966144T 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer ATE398623T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ATE398623T1 true ATE398623T1 (de) 2008-07-15

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966144T ATE398623T1 (de) 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Country Status (25)

Country Link
US (2) US6649651B1 (de)
EP (1) EP1222192B8 (de)
JP (1) JP4951179B2 (de)
KR (1) KR100792391B1 (de)
CN (1) CN1191256C (de)
AP (1) AP1459A (de)
AT (1) ATE398623T1 (de)
AU (1) AU781656B2 (de)
BR (1) BR0014602A (de)
CA (1) CA2386850C (de)
CZ (1) CZ300031B6 (de)
DE (1) DE60039244D1 (de)
DK (1) DK1222192T3 (de)
ES (1) ES2307533T3 (de)
HU (1) HU228938B1 (de)
IL (2) IL149005A0 (de)
MX (1) MXPA02003607A (de)
NO (1) NO327996B1 (de)
NZ (1) NZ518580A (de)
OA (1) OA12053A (de)
PL (1) PL204924B1 (de)
RU (1) RU2247123C2 (de)
SK (1) SK287153B6 (de)
WO (1) WO2001025240A1 (de)
ZA (1) ZA200202655B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2386850C (en) * 1999-10-06 2010-03-30 Piet Tom Bert Paul Wigerinck Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
EP1397367A2 (de) 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Breitspektrum-2-(amino substituierte)-benzoxazol-sulfonamid-hiv-protease-inhibitoren für die entdeckung entfernter zellulärer signale durch nukleozytoplasmatisches zyklisieren
CN100519561C (zh) 2001-09-10 2009-07-29 泰博特克药品有限公司 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
US7109230B2 (en) * 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
CA2485903C (en) 2002-05-17 2011-08-16 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
OA12893A (en) * 2002-08-02 2006-10-13 Tibotec Pharm Ltd Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.
EP1589018A4 (de) 2002-12-27 2007-03-14 Sumitomo Chemical Co Herstellungsverfahren für hexahydrofurofuranol-derivate, zwischenprodukt davon und herstellungsverfahren dafür
WO2005087728A1 (en) * 2004-03-11 2005-09-22 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
TWI383975B (zh) 2004-03-31 2013-02-01 悌柏泰克醫藥有限公司 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
KR101477822B1 (ko) 2006-07-07 2015-01-02 길리애드 사이언시즈, 인코포레이티드 치료제의 약동학 특성의 모듈레이터
JP2009544708A (ja) * 2006-07-24 2009-12-17 ギリアード サイエンシーズ, インコーポレイテッド ビスフラニルプロテアーゼ阻害剤
RS51675B (sr) 2006-11-09 2011-10-31 Tibotec Pharmaceuticals Metode za dobivanje heksahidrofuro[2,3-b]furan-3-ola
WO2008133734A2 (en) 2006-11-21 2008-11-06 Purdue Research Foundation Method and compositions for treating hiv infections
PT3150586T (pt) 2007-02-23 2020-03-31 Gilead Sciences Inc Moduladores de propriedades farmacocinéticas de agentes terapêuticos
EP2134336B1 (de) 2007-03-16 2013-12-11 Sequoia Pharmaceuticals Von benzofuran stammende hiv-protease-hemmer
KR20100040896A (ko) 2007-07-06 2010-04-21 길리애드 사이언시즈, 인코포레이티드 치료제의 약동학적 특성의 조절제
PT2231628E (pt) 2008-01-04 2015-12-29 Gilead Sciences Inc Inibidores de citocromo p450
WO2009091941A1 (en) * 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
EP2307345A4 (de) 2008-07-01 2012-05-02 Purdue Research Foundation Nichtpeptidinhibitoren der hiv-1-protease
US8501961B2 (en) 2008-07-09 2013-08-06 Purdue Research Foundation HIV protease inhibitors and methods for using
ES2600878T3 (es) 2009-12-21 2017-02-13 Janssen Sciences Ireland Uc Implante removible, degradable, para la liberación prolongada de un compuesto activo
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
EP2883858B1 (de) * 2012-08-09 2017-12-27 Sumitomo Chemical Company Limited Verfahren zur herstellung eines hexahydrofurofuranolderivats
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2142998C (en) * 1992-08-25 2008-01-29 Michael L. Vazquez N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
DE122007000045I2 (de) * 1992-08-25 2011-07-21 Gd Searle Llc Gd Searle Llc Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
ES2127938T3 (es) * 1993-08-24 1999-05-01 Searle & Co Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt) * 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
CA2386850C (en) * 1999-10-06 2010-03-30 Piet Tom Bert Paul Wigerinck Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor

Also Published As

Publication number Publication date
AP2002002472A0 (en) 2002-06-30
NO327996B1 (no) 2009-11-02
HUP0203130A2 (hu) 2003-01-28
CN1407987A (zh) 2003-04-02
CN1191256C (zh) 2005-03-02
EP1222192B1 (de) 2008-06-18
KR100792391B1 (ko) 2008-01-08
PL354351A1 (en) 2004-01-12
IL149005A (en) 2006-12-31
JP2003511383A (ja) 2003-03-25
NO20021598D0 (no) 2002-04-04
US6649651B1 (en) 2003-11-18
NZ518580A (en) 2004-01-30
BR0014602A (pt) 2002-06-11
MXPA02003607A (es) 2003-07-28
HUP0203130A3 (en) 2005-01-28
SK5702002A3 (en) 2003-01-09
AU781656B2 (en) 2005-06-02
CZ20021419A3 (cs) 2002-10-16
HK1054746A1 (en) 2003-12-12
PL204924B1 (pl) 2010-02-26
CZ300031B6 (cs) 2009-01-14
HU228938B1 (hu) 2013-06-28
CA2386850C (en) 2010-03-30
OA12053A (en) 2006-05-02
WO2001025240A1 (en) 2001-04-12
EP1222192A1 (de) 2002-07-17
ES2307533T3 (es) 2008-12-01
EP1222192B8 (de) 2008-10-01
NO20021598L (no) 2002-05-29
CA2386850A1 (en) 2001-04-12
US20050261364A1 (en) 2005-11-24
JP4951179B2 (ja) 2012-06-13
RU2247123C2 (ru) 2005-02-27
AP1459A (en) 2005-08-22
US7157495B2 (en) 2007-01-02
DK1222192T3 (da) 2008-10-20
AU7663800A (en) 2001-05-10
SK287153B6 (sk) 2010-01-07
ZA200202655B (en) 2003-09-23
KR20020067503A (ko) 2002-08-22
DE60039244D1 (de) 2008-07-31
IL149005A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
DE60039244D1 (de) HEXAHYDROFUROi2,3-B FURAN-3-YL-N- 3-i(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO -1-BENZYL-2-HYDROXYPROPYL CARBAMAT ALS RETROVIRUSPROTEASEHEMMER
EE200200273A (et) Uudsed diabeedivastased agensid
DE60036365D1 (de) Klappankersystem für einen schutzschalter
DE60036411D1 (de) Schlagwerkzeug
ITBO990171A0 (it) Macchina depallettizzatrice .
FI19992482L (fi) Sovitelma laivaa varten
ID29961A (id) Alat penakar
DE50013707D1 (de) Handwerkzeugmaschine
ID26595A (id) Alat pemilah
ATE265449T1 (de) 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridin wirksam als herbizide
NO20013338L (no) Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer
DE50203244D1 (de) Gleisbaumaschine
DE60008492D1 (de) Griffanordnung für koffer
DE50010145D1 (de) Handwerkzeugmaschine
EP1106686A4 (de) Artiodactyl-epimorphin
DE60002404D1 (de) Verbessertes handwerkzeug
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
DE59912578D1 (de) Turbomaschinenschaufel
EP1195163A4 (de) Serinprotease-inhibitoren
FI4404U1 (fi) Liitosyhde
DE50014406D1 (de) Handwerkzeugmaschine
ITLU990008V0 (it) Spalla portante a pettine
FI3926U1 (fi) Kaasupesuri
IT1303478B1 (it) Irrigatore a reazione.
ES1048338Y (es) Maquina modular de musculacion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties